AI could be the best tool ever for accelerating scientific discovery, marking the beginning of a new golden age of discovery powered by AI tools like AlphaFold.

More than 2 million researchers worldwide now use AlphaFold, and it has had a significant impact on biology and medical research, but this is just the beginning of AI's potential in science.

The advancements in AI, such as AlphaFold, are revolutionizing fields like medicine, enabling us to design proteins that can potentially cure diseases like cancer.

At Google DeepMind, we've been applying AI across almost every branch of science, achieving breakthroughs in areas from mathematics to life sciences, including developing AlphaProof for solving Math Olympiad problems and AlphaFold for predicting molecular structures.

The first generation of AI applications in drug design often focused on local models, but our approach is to build a more comprehensive system that can generalize across various tasks, as demonstrated by AlphaFold 3, which allows us to create models that generalize across chemistry and target space, enabling application to any protein or small molecule without needing fine-tuning.

We're excited about Alpha Evolve because it represents the beginning of an automated process in AI research, although it's still relatively narrow in application. We can now generate novel ideas that advance the state-of-the-art in AI, going beyond just analyzing existing data.

The launch of the AlphaFold server is crucial for providing the scientific community with access to our models, facilitating non-commercial academic research.

AI is expected to change mathematics significantly, with projects like AlphaProof focusing on proving conjectures and potentially leading to new interesting conjectures in the future.

AlphaFold has become a standard tool for biology and medical research, with over 2.5 million researchers worldwide using it in their critical work, significantly impacting the scientific community.